Suppr超能文献

L.:对其民族医学、植物化学、药理学及临床应用的全面综述。

L.: a comprehensive review of its ethnomedicine, phytochemistry, pharmacology, and clinical applications.

作者信息

Bai Haotian, Yang Jing, Wang Rui

机构信息

College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China.

College of Basic Medical Science, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China.

出版信息

Front Pharmacol. 2025 Aug 21;16:1609299. doi: 10.3389/fphar.2025.1609299. eCollection 2025.

Abstract

BACKGROUND

L. has a long history of ethnomedicinal use for various ailments. This review focuses on the botany, ethnopharmacology, phytochemistry, pharmacological effects, and clinical applications of safflower, aiming to enhance current research in this field.

METHODS

The study incorporated relevant scientific literature up to April 2025. It involved the collection of both Chinese and English studies on safflower from various databases, including PubMed, Elsevier, Web of Science, Springer, ScienceDirect, Wiley, ACS, and CNKI (China National Knowledge Infrastructure). Additionally, doctoral and master's dissertations were included in the analysis.

RESULTS

From 1978 to April 2025, various active metabolites were identified, primarily comprising flavonoids, polyacetylenes, and alkaloids, with flavonoids being the predominant group. Extracts and metabolites derived from safflower have demonstrated a range of bioactivities, including antioxidant, hepatoprotective, anti-inflammatory, and anticancer effects. In clinical practice, the effective components of safflower have been utilized in the treatment of cardiovascular and cerebrovascular diseases, diabetes, hepatobiliary conditions, poor blood circulation, sudden deafness, and other ailments.

CONCLUSION

This review elucidates the research surrounding safflower in the domains of ethnopharmacology, phytochemistry, pharmacological activity, and clinical applications. Safflower is known to contain a diverse array of compounds, with flavonoids in particular demonstrating significant pharmacological activity. These compounds are extensively utilized in the pharmaceutical, food, and cosmetic industries, positioning safflower as a promising candidate for development and application in the treatment of various diseases. Nonetheless, research on safflower remains limited, and many active metabolites have yet to be thoroughly investigated in terms of their phytochemical and pharmacological properties. To date, only a handful of active metabolites have been isolated and assessed for their biological activity, and there is a notable deficiency in research regarding their mechanisms of action. Therefore, comprehensive studies are imperative to enhance our understanding of safflower and to substantiate its therapeutic potential.

摘要

背景

L. 在民族医学中有着长期用于治疗各种疾病的历史。本综述聚焦于红花的植物学、民族药理学、植物化学、药理作用及临床应用,旨在加强该领域的现有研究。

方法

该研究纳入了截至2025年4月的相关科学文献。研究涉及从多个数据库收集有关红花的中英文研究,这些数据库包括PubMed、爱思唯尔、科学网、施普林格、科学Direct、威利、美国化学学会和中国知网(中国国家知识基础设施)。此外,分析还包括博士和硕士学位论文。

结果

1978年至2025年4月期间,已鉴定出多种活性代谢产物,主要包括黄酮类、聚乙炔类和生物碱类,其中黄酮类是主要类别。红花提取物和代谢产物已显示出一系列生物活性,包括抗氧化、保肝、抗炎和抗癌作用。在临床实践中,红花的有效成分已被用于治疗心脑血管疾病、糖尿病、肝胆疾病、血液循环不良、突发性耳聋及其他疾病。

结论

本综述阐明了红花在民族药理学、植物化学、药理活性和临床应用领域的研究情况。已知红花含有多种化合物,尤其是黄酮类化合物显示出显著的药理活性。这些化合物广泛应用于制药、食品和化妆品行业,使红花成为治疗各种疾病的开发和应用的有前景候选物。尽管如此,对红花的研究仍然有限,许多活性代谢产物在植物化学和药理特性方面尚未得到充分研究。迄今为止,仅分离出少数活性代谢产物并评估了其生物活性,而且关于其作用机制的研究存在明显不足。因此,进行全面研究对于增进我们对红花的理解并证实其治疗潜力至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07a/12408597/5efa59a0c9f7/fphar-16-1609299-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验